Literature DB >> 11374696

Gender-related differences in the clinical course of Crohn's disease.

M J Wagtmans1, H W Verspaget, C B Lamers, R A van Hogezand.   

Abstract

OBJECTIVE: The aim of this study was to analyze the clinical and epidemiological differences between women and men affected by Crohn's disease.
METHODS: The clinical course of 275 female Crohn's disease patients was compared with that of 266 male patients.
RESULTS: Mean age at onset of symptoms and at diagnosis was 25.7 yr versus 27.7 yr and 28.8 yr versus 30.7 yr in women and men, respectively. Mean lag-time between onset of symptoms and establishment of the diagnosis were similar in both groups, without differences in presenting symptoms and initial localization of lesions. In women, however, some extraintestinal manifestations of Crohn's disease were found to occur more often. The percentage of patients who underwent an abdominal operation was quite similar in both groups (81% vs 77%). Mean lag-time between onset of symptoms and first bowel resection was not different. However, the lag-time between bowel resection and recurrence of disease was significantly shorter in women than in men (respectively, 4.8 yr vs 6.5 yr, p = 0.04), particularly regarding primary ileocecal resections. Overall, ileocecal resections were significantly more frequently performed in female than male patients (44% and 32%, respectively, p = 0.004). Female patients were also found to have significantly more often relatives in the first or second degree affected by Crohn's disease than male patients (15% vs 8.3%, p = 0.02).
CONCLUSIONS: Extraintestinal manifestations occur more often in female Crohn's disease patients than in male patients. Furthermore, an ileocecal resection, which is accompanied by an earlier recurrence, is more often performed in female than in male patients. Female patients have more often relatives with the same disease.

Entities:  

Mesh:

Year:  2001        PMID: 11374696     DOI: 10.1111/j.1572-0241.2001.03755.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

1.  Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.

Authors:  James R Irwin; Emma Ferguson; Lisa A Simms; Katherine Hanigan; James D Doecke; Daman Langguth; Ashley Arnott; Graham Radford-Smith
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

2.  Transmission distortion in Crohn's disease risk gene ATG16L1 leads to sex difference in disease association.

Authors:  Linda Y Liu; Marc A Schaub; Marina Sirota; Atul J Butte
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

3.  Evaluation of possible inflammatory bowel disease: a survey of Rhode Island physicians.

Authors:  Sumona Saha; Manuel Lam; Erica Roberson; Samir Shah; Neal S LeLeiko; Sheldon Lidofsky; Renee Bright; Nicole Flowers; Marjorie Merrick; Bruce E Sands
Journal:  Med Health R I       Date:  2012-01

Review 4.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

5.  Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens.

Authors:  Janka Bábíčková; Ľubomíra Tóthová; Eva Lengyelová; Anastázie Bartoňová; Július Hodosy; Roman Gardlík; Peter Celec
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

6.  Impact of sex on 30-day complications and long-term functional outcomes following ileal pouch-anal anastomosis for chronic ulcerative colitis.

Authors:  Nicholas P McKenna; Eric J Dozois; John H Pemberton; Amy L Lightner
Journal:  Int J Colorectal Dis       Date:  2018-03-16       Impact factor: 2.571

7.  Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart review.

Authors:  Joseph Tkacz; Jennifer H Lofland; Julie Vanderpoel; Charles Ruetsch
Journal:  Am Health Drug Benefits       Date:  2014-04

8.  Assessment of Sex Differences for Treatment, Procedures, Complications, and Associated Conditions Among Adolescents Hospitalized with Crohn's Disease.

Authors:  Jennifer L Dotson; Josh B Bricker; Michael D Kappelman; Deena Chisolm; Wallace V Crandall
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

9.  Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.

Authors:  Martin J W Meijer; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Daniel W Hommes; Hein W Verspaget
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

10.  Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus.

Authors:  Xian-Rui Wu; Jean Ashburn; Feza H Remzi; Yi Li; Hagar Fass; Bo Shen
Journal:  J Gastrointest Surg       Date:  2015-10-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.